The sale of a significant number of shares by a selling stockholder often leads to concerns about dilution of equity for existing shareholders. This can result in a negative perception among investors, potentially leading to a short-term decrease in stock price. The relevance is high as the news directly involves Vivos Therapeutics Inc, and the importance is significant due to the potential impact on shareholder value. The confidence level is based on typical market reactions to similar equity actions.